Cargando…

Analysis of C3 Gene Variants in Patients With Idiopathic Recurrent Spontaneous Pregnancy Loss

Miscarriage is the most common complication of pregnancy. Approximately 1% of couples trying to conceive will experience recurrent miscarriages, defined as three or more consecutive pregnancy losses and many of these cases remain idiopathic. Complement is implicated both in the physiology and pathol...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohlin, Frida C., Gros, Piet, Mercier, Eric, Gris, Jean-Christophe Raymond, Blom, Anna M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090058/
https://www.ncbi.nlm.nih.gov/pubmed/30131807
http://dx.doi.org/10.3389/fimmu.2018.01813
_version_ 1783347132665692160
author Mohlin, Frida C.
Gros, Piet
Mercier, Eric
Gris, Jean-Christophe Raymond
Blom, Anna M.
author_facet Mohlin, Frida C.
Gros, Piet
Mercier, Eric
Gris, Jean-Christophe Raymond
Blom, Anna M.
author_sort Mohlin, Frida C.
collection PubMed
description Miscarriage is the most common complication of pregnancy. Approximately 1% of couples trying to conceive will experience recurrent miscarriages, defined as three or more consecutive pregnancy losses and many of these cases remain idiopathic. Complement is implicated both in the physiology and pathology of pregnancy. Therefore, we hypothesized that alterations in the C3 gene could potentially predispose to this disorder. We performed full Sanger sequencing of all exons of C3, in 192 childless women, with at least two miscarriages and without any known risk factors. All exons carrying non-synonymous alterations found in the patients were then sequenced in a control group of 192 women. None of the identified alterations were significantly associated with the disorder. Thirteen identified non-synonymous alterations (R102G, K155Q, L302P, P314L, Y325H, V326A, S327P, V330I, K633R, R735W, R1591G, G1606D, and S1619R) were expressed recombinantly, upon which C3 expression and secretion were determined. The L302P and S327P were not secreted from the cells, likely due to misfolding and intracellular degradation. Y325H, V326A, V3301I, R1591G, and G1606D yielded approximately half C3 concentration in the cell media compared with wild type (WT). We analyzed the hemolytic activity of the secreted C3 variants by reconstituting C3-depleted serum. In this assay, R1591G had impaired hemolytic activity while majority of remaining mutants instead had increased activity. R1591G also yielded more factor B activation in solution compared with WT. R1591G and G1606D showed impaired degradation by factor I, irrespectively if factor H, CD46, or C4b-binding protein were used as cofactors. These two C3 mutants showed impaired binding of the cofactors and/or factor I. Taken together, several alterations in C3 were identified and some of these affected the secretion and/or the function of the protein, which might contribute to the disorder but the degree of association must be evaluated in larger cohorts.
format Online
Article
Text
id pubmed-6090058
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-60900582018-08-21 Analysis of C3 Gene Variants in Patients With Idiopathic Recurrent Spontaneous Pregnancy Loss Mohlin, Frida C. Gros, Piet Mercier, Eric Gris, Jean-Christophe Raymond Blom, Anna M. Front Immunol Immunology Miscarriage is the most common complication of pregnancy. Approximately 1% of couples trying to conceive will experience recurrent miscarriages, defined as three or more consecutive pregnancy losses and many of these cases remain idiopathic. Complement is implicated both in the physiology and pathology of pregnancy. Therefore, we hypothesized that alterations in the C3 gene could potentially predispose to this disorder. We performed full Sanger sequencing of all exons of C3, in 192 childless women, with at least two miscarriages and without any known risk factors. All exons carrying non-synonymous alterations found in the patients were then sequenced in a control group of 192 women. None of the identified alterations were significantly associated with the disorder. Thirteen identified non-synonymous alterations (R102G, K155Q, L302P, P314L, Y325H, V326A, S327P, V330I, K633R, R735W, R1591G, G1606D, and S1619R) were expressed recombinantly, upon which C3 expression and secretion were determined. The L302P and S327P were not secreted from the cells, likely due to misfolding and intracellular degradation. Y325H, V326A, V3301I, R1591G, and G1606D yielded approximately half C3 concentration in the cell media compared with wild type (WT). We analyzed the hemolytic activity of the secreted C3 variants by reconstituting C3-depleted serum. In this assay, R1591G had impaired hemolytic activity while majority of remaining mutants instead had increased activity. R1591G also yielded more factor B activation in solution compared with WT. R1591G and G1606D showed impaired degradation by factor I, irrespectively if factor H, CD46, or C4b-binding protein were used as cofactors. These two C3 mutants showed impaired binding of the cofactors and/or factor I. Taken together, several alterations in C3 were identified and some of these affected the secretion and/or the function of the protein, which might contribute to the disorder but the degree of association must be evaluated in larger cohorts. Frontiers Media S.A. 2018-08-07 /pmc/articles/PMC6090058/ /pubmed/30131807 http://dx.doi.org/10.3389/fimmu.2018.01813 Text en Copyright © 2018 Mohlin, Gros, Mercier, Gris and Blom. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Mohlin, Frida C.
Gros, Piet
Mercier, Eric
Gris, Jean-Christophe Raymond
Blom, Anna M.
Analysis of C3 Gene Variants in Patients With Idiopathic Recurrent Spontaneous Pregnancy Loss
title Analysis of C3 Gene Variants in Patients With Idiopathic Recurrent Spontaneous Pregnancy Loss
title_full Analysis of C3 Gene Variants in Patients With Idiopathic Recurrent Spontaneous Pregnancy Loss
title_fullStr Analysis of C3 Gene Variants in Patients With Idiopathic Recurrent Spontaneous Pregnancy Loss
title_full_unstemmed Analysis of C3 Gene Variants in Patients With Idiopathic Recurrent Spontaneous Pregnancy Loss
title_short Analysis of C3 Gene Variants in Patients With Idiopathic Recurrent Spontaneous Pregnancy Loss
title_sort analysis of c3 gene variants in patients with idiopathic recurrent spontaneous pregnancy loss
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090058/
https://www.ncbi.nlm.nih.gov/pubmed/30131807
http://dx.doi.org/10.3389/fimmu.2018.01813
work_keys_str_mv AT mohlinfridac analysisofc3genevariantsinpatientswithidiopathicrecurrentspontaneouspregnancyloss
AT grospiet analysisofc3genevariantsinpatientswithidiopathicrecurrentspontaneouspregnancyloss
AT merciereric analysisofc3genevariantsinpatientswithidiopathicrecurrentspontaneouspregnancyloss
AT grisjeanchristopheraymond analysisofc3genevariantsinpatientswithidiopathicrecurrentspontaneouspregnancyloss
AT blomannam analysisofc3genevariantsinpatientswithidiopathicrecurrentspontaneouspregnancyloss